Mrs. Keri Kathleen Rassi, ARNP, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 712 S Ocean Shore Blvd Ste 107, Flagler Beach, FL 32136 Phone: 386-631-5675 Fax: 866-728-2444 |
Ms. Patricia Kay Turbyfill, ARNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 811 N Oceanshore Blvd, Flagler Beach, FL 32136 Phone: 386-439-4224 Fax: 386-439-4202 |
News Archive
New research reveals that the greatest demand for liver transplantation due to hepatitis C (HCV)-related liver disease occurs among Americans born between 1941 and 1960. Findings in the December issue of Liver Transplantation, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD), suggest that continuing increased demand for transplantation is driven by the development of liver cancer in baby boomers with HCV, but that the demand may decrease as patients born in this time period continue to grow older.
Zephyr Technology is proud to announce the release of ZephyrLIFE - the world's first remote monitoring system designed specifically for the growing market of transitional care. Transitional care involves managing the continuity of health care during the transition between health care practitioners and facilities as a patient's condition and care needs change during the course of a chronic or acute illness, which ZephyrLIFE has been designed for.
CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price.
Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, today announced the completion by its subsidiary, Sinovac Beijing, of the acquisition of buildings and land use rights. The total consideration for the purchase is approximately RMB120 million ($17.6 million), which will be financed from working capital. The initial payment of RMB56.5 million ($8.3 million) will be paid before February 20, 2010 and the balance of the purchase price will be paid in three installments within three years.
University of Hawai'i Cancer Center researchers discovered a novel therapeutic target and treatment strategy for acute myeloid leukemia, a cancer of the blood and bone marrow that normally requires prompt and aggressive treatment.
› Verified 3 days ago